Page last updated: 2024-08-26

sr141716 and 2-iodophenyl-(1-(1-methylpiperidin-2-ylmethyl)-1h-indol-3-yl)methanone

sr141716 has been researched along with 2-iodophenyl-(1-(1-methylpiperidin-2-ylmethyl)-1h-indol-3-yl)methanone in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akinfeleye, T; Bruneus, M; Deng, H; Dhawan, J; Dimaio, AA; Gatley, SJ; Gifford, AN; Makriyannis, A1

Other Studies

1 other study(ies) available for sr141716 and 2-iodophenyl-(1-(1-methylpiperidin-2-ylmethyl)-1h-indol-3-yl)methanone

ArticleYear
Evaluation of the in vivo receptor occupancy for the behavioral effects of cannabinoids using a radiolabeled cannabinoid receptor agonist, R-[125/131I]AM2233.
    Synapse (New York, N.Y.), 2006, Volume: 60, Issue:2

    Topics: Animals; Behavior, Animal; Benzoxazines; Binding Sites; Binding, Competitive; Brain; Cannabinoids; Dose-Response Relationship, Drug; Drug Interactions; Indoles; Iodine Radioisotopes; Male; Mice; Morpholines; Motor Activity; Naphthalenes; Neurons; Piperidines; Protein Conformation; Pyrazoles; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant

2006